(Q46454840)
Statements
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer (English)
A Santoro
A Comandone
C Granetti
V Lorusso
C Oliva
M Zuradelli
E Mari
T Pressiani